FTLF

 
Common Stock SEC Reporting - Current
OTC Pink Current Information
Contact Info
  • 4509 S. 143rd Street
  • Suite 1
  • Omaha, NE 68137

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001374328
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Michael Abrams Interim CFO
John S. Wilson President, CEO
Warren Rothouse IR
Company Directors
Michael Abrams
Lewis Jaffe
Dayton Judd
Todd Ordal
John S. Wilson
Seth Yakatan
Company Notes
  • Formerly=Bond Laboratories, Inc. until 9-2013
Service Providers
Accounting/Auditing Firm
Tarvaran Askelson & Company, LLP
35565 B Golden Lantern
Suite 509
Dana Point, CA, 92629
United States

Legal Counsel
Not Available
Investor Relations Firm
Network 1 Financial Securities
The Galleria Building, 2 Bridge Avenue
4th Floor
Red Bank, NJ, 07701
United States

FTLF Security Details
Share Structure
Market Value1 $3,308,909 a/o Sep 25, 2017
Authorized Shares Not Available
Outstanding Shares 10,504,472 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Transfer Agent(s)
Shareholders
Shareholders of Record 231 a/o Apr 17, 2017
Short Selling Data
Short Interest 2,500 (2,559.57%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security